Idoven AI-powered Cardiovascular Care

by Idoven  · Based in Spain →AI-powered detection and precision medicine for cardiology
Cardiology Emergency Medicine Internal Medicine

Contact for pricing
Regulatory Status Disclosed

Overview

Idoven AI-powered Cardiovascular Care is a cloud-based, cardiology-as-a-service platform designed to assist healthcare professionals in identifying, triaging, and diagnosing cardiac arrhythmias and patterns at scale.

The platform is built for cardiologists, electrophysiologists, primary care physicians, and clinical researchers across various care settings, including hospitals, remote monitoring programs, and clinical trials. It serves medical device manufacturers (MedTech) and pharmaceutical companies (Life Sciences) by supporting digital diagnostics, patient risk stratification, and cardiac drug safety monitoring.

Integrating into clinical workflows, the software is device-neutral and ingests electrocardiogram (ECG) data of any duration (from 30 seconds to 30 days) in standard formats such as EDF, HL7, DICOM, JSON, XML, and PDF. It processes data from ambulatory ECGs (holters and patches), standard 12-lead resting ECGs, and insertable cardiac monitors (ICMs) via API or non-API tools to deliver analysis within minutes.

Notable capabilities of its core AI engine, Willem, include:

  • Automatic detection of 22 cardiac patterns and 4 key intervals (P interval, PR interval, QT interval, and QRS duration).
  • CE Mark certification as a Class IIa Medical Device under the EU Medical Device Regulation (MDR) 2017/745.
  • Compliance with ISO 13485, ISO 27001, and GDPR standards for data security and privacy.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Key Features

  • AI-powered ECG interpretation and prediction
  • Detection of 22 cardiac patterns and 4 intervals
  • Device-neutral and interoperable with various ECG devices and EHR systems
  • Cloud-based platform for rapid analysis and results in minutes
  • Disease risk scores using ECG-based biomarkers
  • Continuous remote ECG monitoring from non-invasive devices
  • Reduction of false positive detections in ICMs by 98%
  • Integration into existing clinical and research workflows
  • Secure cloud infrastructure with ISO 27001, 27017, 27018, 27701, 13485, 37001, 42001 certifications and Spanish National Security Scheme
  • Ability to analyze ECGs of any duration (30 seconds to 30 days)

Use Cases

  • Rapid and accurate identification of arrhythmias and cardiac patterns for MedTech companies
  • Development of digital biomarkers for Life Sciences, including prediction, cardiotoxicity, and risk stratification
  • Preventative screening programs with continuous remote ECG monitoring and medical-grade reports
  • Streamlining and standardizing cardiovascular safety monitoring during clinical trials and post-market approval for pharmaceutical companies
  • Triage and diagnosis of patients at scale, reducing manual workload for physicians
  • Early detection of heart failure in primary care

What Physicians Need to Know

ECG/EKG Analysis Capability
Idoven's AI-powered platform, Willem, analyzes ECG data from various devices (1-lead wearables, patches, 12-lead hospital ECGs, Holters, and Insertable Cardiac Monitors) to detect 23 unique cardiac patterns with cardiologist-level accuracy. It can analyze 30-second ECGs in seconds and 24-hour Holters in under 5 minutes, significantly improving speed, consistency, and accuracy of interpretation.
Echocardiography AI Features
While Idoven primarily focuses on ECG analysis, AI in echocardiography is a developing field that enables patient-specific cardiovascular assessment for targeted therapy, cardiotoxicity risk prediction, and cardiomyopathy risk stratification. Idoven's core offering is ECG-based, but their platform's device neutrality and interoperability could potentially integrate with future echocardiography AI outputs.
Cardiac CT/MRI Analysis
Idoven's current offerings do not explicitly detail Cardiac CT/MRI analysis capabilities. Their primary focus is on leveraging AI for ECG interpretation and prediction.
Arrhythmia Detection Accuracy
Idoven's AI algorithm has demonstrated high accuracy in arrhythmia detection. It achieved 96.4% accuracy in detecting atrial fibrillation (AF) from single-lead ECGs. In collaboration with Abbott, Idoven's AI improved ICM accuracy by 95.4% for arrhythmia detection and reduced false positives by 98%. The platform can identify 86 electrical heart disturbances, covering 90% of common cardiac problems.
Heart Failure Risk Prediction
Idoven develops disease risk scores using ECG-based biomarkers to identify high-risk patients for various cardiovascular diseases. They have a model that identifies patients at increased risk of developing persistent atrial fibrillation within the next 6 months. Idoven is also collaborating on projects to detect heart failure, including an initiative with AstraZeneca and Fitbit to identify and monitor high-risk patients in minutes. The FAITHFUL Consortium, led by Idoven, aims to revolutionize heart failure detection in primary care, with a goal to reduce hospital admissions by 40%.
Coronary Artery Assessment
Idoven's ASSIST Consortium is developing the world's first AI-based solution for early diagnosis and accurate triage of acute myocardial infarction (heart attack), which involves the obstruction of coronary arteries. This project aims to improve accuracy and reduce diagnosis time by up to 67%.
Cardiac Monitoring Integration
Idoven's solution is device-neutral and interoperable, capable of analyzing data from various monitoring devices including wearables, patches, Holters, and implantable cardiac monitors (ICMs). They offer continuous remote ECG monitoring from non-invasive devices and integrate seamlessly into clinical workflows via API and non-API tools.
AHA/ACC Guideline Alignment
Idoven's platform, Willem, is a CE-marked medical device software, compliant with EU MDR regulations for the assessment of arrhythmias. While specific alignment with AHA/ACC guidelines is not explicitly stated, their focus on medical-grade reports and peer-reviewed publications suggests adherence to high clinical standards.
Real-Time Alert Capability
Idoven's platform aims to provide results in 'almost real-time,' with 30-second ECGs analyzed in seconds. Clinicians can monitor patients remotely and receive alerts for troublesome trends in real-time, enabling intervention before hospitalization.
Physician Tip

Idoven's AI can significantly reduce the manual burden of ECG interpretation, allowing for faster and more accurate diagnoses, especially for high volumes of data from continuous monitoring devices. Leverage its predictive capabilities for early identification of high-risk patients, particularly for conditions like atrial fibrillation and heart failure. The device-neutral nature allows for integration with existing monitoring infrastructure. Remember that while the AI provides cardiologist-level accuracy, it serves as an advisory tool and should be used in conjunction with your clinical expertise and patient history.

Idoven's platform is designed for device neutrality and interoperability, supporting data exchange via API and non-API tools (EDF, HL7, DICOM, JSON, XML, PDF). They have established collaborations with major players like AstraZeneca and Google's Fitbit for heart failure detection and remote monitoring, and with Abbott for improving arrhythmia detection in implantable cardiac monitors. The platform seamlessly integrates with current EMR and patient management systems to avoid changes in clinical workflow.

Details

Category Cardiology AI, Clinical Decision Support & Reference
Pricing Contact for pricing
DeploymentCloud-based
Compliance
BAA AvailableUnknown AI-estimated
HIPAA CompliantUnknown AI-estimated
FDA Status Eu mdr class iia AI-estimated

Idoven's ECG analysis platform, Willem™, is certified as a Medical Device Class IIa under the EU Medical Device Regulation (EU MDR) 2017/745 for the assessment of arrhythmias by qualified healthcare professionals using ECG data. It is capable of detecting 22 cardiac patterns and 4 intervals across various ECG recording device types.

Integrations
EHR Not specified
Specialties Cardiology, Emergency Medicine, Internal Medicine

What the Web Says

Idoven AI-powered Cardiovascular Care, utilizing its Willemu2122 platform, is an AI-driven cardiology solution designed to enhance the detection and diagnosis of heart conditions through advanced ECG analysis. It aims to augment clinicians' abilities by providing rapid, accurate, and consistent interpretation of large volumes of ECG data, ultimately leading to earlier detection, more precise treatment, and improved patient outcomes.

Overall: Positive

Strengths

  • High-accuracy AI-driven ECG interpretation, detecting numerous cardiac patterns and intervals with reported accuracy rates up to 96.4% for atrial fibrillation.
  • Seamless integration with various ECG devices (device-agnostic) and existing healthcare infrastructures (EMR, APIs), breaking down data silos.
  • Significantly reduces ECG analysis time from months to minutes, freeing up cardiologists' time for direct patient care.
  • Robust data security and compliance standards, including ISO certifications and GDPR compliance.
  • Potential for predictive and preventative cardiology, identifying high-risk patients and monitoring cardiac drug safety.
  • Reduces false positives in arrhythmia detection, improving diagnostic efficiency and easing clinician workload.

Limitations

  • No publicly available pricing information, as it's primarily designed for enterprise-level implementation.
  • Requires initial setup and integration efforts within existing healthcare systems.
  • Reliance on mobile connectivity may limit some users.
  • As with many AI medical tools, there's a need for continued high-quality studies and clinical validation across diverse populations.
  • Potential for algorithmic biases if training data does not represent diverse patient populations.
  • Lack of interpretability in some AI systems can undermine clinician trust.

Based on reviews from: AIChief, Health tech start-up uses AI to redefine cardiology care, Idoven | AI-powered Cardiovascular Care, Idoven AI: A Deep Dive into AI-Powered Electrocardiogram Analysis - Skywork, Powering the future of cardiology with AI, Idoven - Google for Startups, The Power of Idoven's AI: Bringing high-quality cardiology care to people across the seven continents, ASSIST Consortium: AI-Powered Early Diagnosis for Heart Attacks - Idoven, Investigating the Efficacy of AI-Powered Innovations in ECG Analysis and Continuous Heart Monitoring: A Comprehensive Narrative Review - PMC, AstraZeneca and Idoven are using Artificial Intelligence to diagnose heart failure through a pioneering project in Europe, Insight and Northzone back AI heart disease prediction tech Idoven | Sifted, Why we invested in Idoven, the leading cardiologist-as-a-service platform powered by AI | by Pascual Cortes-Monroy | Northzone | Medium, Willem, Idoven's AI Platform, achieves 96.4% accuracy in atrial fibrillation detection from 1-lead ECGs, We analysed 50,000 heartbeats in less than 1 minute using 16 | IDOVEN, Idoven Raises $19.8 Million in Funding to Redefine Detection and Precision Medicine of Cardiovascular Diseases with AI - PR Newswire, Cardiologists working with AI said it was equal or better than human cardiologists in most areas - Reddit, Use Case Diagnose | Deliver Accurate Triage & Diagnosis - Idoven, Blog - Idoven, The Use of AI in Cardiovascular Care u2013 A Review - Premier Science, General vs HF vs EP in an AI Driven World : r/Cardiology - Reddit, Randomized Controlled Trials Evaluating Artificial Intelligence in Cardiovascular Care: A Systematic Review - PMC

Last updated: 2026-07-02

Ratings & Reviews

No reviews yet. Be the first to review this tool!

Rate Idoven AI-powered Cardiovascular Care

Clinical Value
Ease of Use
Integration
Support & Docs
Value for Money

Press & Coverage

Idoven
AstraZeneca and Idoven launch the CONCERTO project to improve early diagnosis of patients with amyloidosis
AstraZeneca and Idoven have partnered to launch the CONCERTO project, aiming to enhance early diagnosis of amyloidosis using Idoven's AI model, Willemu2122, to detect subtle patterns in ECGs. This collaboration seeks to reduce the significant diagnostic delays often experienced by patients with this rare and underdiagnosed disease.
2025-05
Idoven
Idoven on the cover of Google's Forward magazine: AI shaping Europe's future
Idoven was featured on the cover of Google's Forward magazine, highlighting its role in how AI is shaping Europe's future in healthcare. This coverage emphasizes Idoven's advancements in AI-driven cardiology.
2025-09
Idoven
CNN featured Idoven and its collaboration with Abbott in finnish hospitals for the Tomorrow Transformed Series
CNN featured Idoven and its collaboration with Abbott in Finnish hospitals as part of the 'Tomorrow Transformed Series,' showcasing their work in AI-driven cardiovascular care.
2025-09
Idoven
Willem, Idoven's AI Platform, achieves 96.4% accuracy in atrial fibrillation detection from 1-lead ECGs
Idoven's AI platform, Willem, has demonstrated high accuracy (96.4%) in detecting atrial fibrillation from 1-lead ECGs, showcasing its potential for improved cardiac diagnostics.
2025-02
Idoven
Donate Your Heartbeats App: turning everyday signals into life-saving knowledge
The 'Donate Your Heartbeats App' by Idoven encourages individuals to contribute their heart data to advance research in preventing cardiovascular diseases.
2025-09
Idoven
Basketball Legend Pau Gasol joins Healthtech Scaleup Idoven in a new round of investment to sustain exceptional growth
Basketball legend Pau Gasol has invested in Idoven, joining the healthtech scaleup to support its continued growth and advancements in AI-powered cardiovascular care.
2024-11

Videos

Product demos, reviews, and walkthroughs for Idoven AI-powered Cardiovascular Care.

Loading videos...

View all on YouTube

Frequently Asked Questions

Idoven's AI platform is designed to seamlessly integrate with current cardiology workflows by providing cloud-based analysis of ECG data. It offers APIs for integration with various Electronic Health Record (EHR) systems, aiming to streamline data flow and minimize disruption to established clinical practices.
Idoven's AI solution has received CE mark certification as a medical device, indicating compliance with European health, safety, and environmental protection standards. The company also states adherence to GDPR and HIPAA for data privacy and security.
Idoven's AI, specifically its platform called 'W precisely', has demonstrated high accuracy in detecting a range of arrhythmias. Studies have shown its capability to identify up to 80 different arrhythmias with high sensitivity and specificity, often surpassing the diagnostic yield of standard ECG interpretation.
While Idoven's AI shows strong performance, potential limitations could include biases if the training data did not adequately represent diverse patient populations, potentially affecting accuracy in certain demographics or rare cardiac conditions. The company continuously works to expand and diversify its datasets to mitigate such biases.
Idoven typically offers a subscription-based pricing model, which can vary depending on the volume of ECGs analyzed and the specific features required. The cost-benefit considerations for a practice or hospital include improved diagnostic efficiency, reduced need for manual review, and potentially earlier intervention for patients, leading to better outcomes and cost savings in the long run.
Alternatives include other AI-powered ECG analysis platforms, traditional Holter monitoring services with human interpretation, and various cardiac wearable devices. Idoven differentiates itself through its advanced AI algorithms capable of detecting a wide range of arrhythmias, its focus on clinical validation, and its seamless integration capabilities with existing healthcare systems.
Idoven provides comprehensive technical support and training for physicians and their staff. This typically includes onboarding assistance, user manuals, online resources, and dedicated support channels to ensure smooth implementation and effective utilization of their AI platform.

Related Tools

Cardiomatics
Cardiomatics
Cardiology AI
Cardiomatics is a cloud-based, AI-powered software for analyzing ambulatory (Holter) ECG tests, using clinically validated algorithms to provide accurate and high-quality results for cardiac diagnostics. It aims to streamline ECG analysis, reduce interpretation time, and improve diagnostic accuracy for various heart conditions.
SafeBeat Rx App
SafeBeat Rx, Inc.
Cardiology AI
An AI application designed to support safe pharmacological treatment and monitoring for cardiac arrhythmias.
PreemptiveAI Clinical SDK
Measure Labs, Inc. (Dba Preemptiveai, Inc.)
Cardiology AI
A clinical software development kit using AI to model and predict cardiovascular health metrics, aiming to shift healthcare from reactive to proactive by providing early health risk signals.
Clarius Ejection Fraction AI
Clarius Mobile Health Corp.
Cardiology AI
Clarius Ejection Fraction AI is an AI-powered ultrasound tool for automated left ventricular ejection fraction calculation, integrated into the Clarius Ultrasound App for real-time cardiac assessments.
Automated Aortic Stenosis Software (AutoAS)
Multiple companies are developing Automated Aortic Stenosis Software (AutoAS) or similar AI-powered solutions. Notable ones include iCardio.ai, Us2.ai, AccurKardia, HeartSciences Inc., and Echo IQ.
Cardiology AI
Automated Aortic Stenosis Software (AutoAS) is an ultrasound application by GE Medical Systems that provides automated assessment of aortic stenosis to enhance diagnostic efficiency and consistency.
ECG-AI Pulmonary Hypertension (PH) 12-Lead algorithm
Anumana
Cardiology AI
An AI algorithm that analyzes standard 12-lead ECG recordings to detect signs of pulmonary hypertension, aiming for earlier diagnosis and improved patient outcomes.

See all Cardiology AI tools →

Suggest an Edit → | Last Verified: 2026-07-01 | First Added: 2026-07-01
AI Tool Finder
AI-powered search. Results may not be comprehensive.